Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Biological Chemistry
Chronic pain caused by nerve damage is tough to treat because its underlying mechanisms aren't well-understood. But new findings by researchers at Harvard Medical School offer hope for those who suffer from this neuropathic pain. Ru-Rong Ji and colleagues report that matrix metalloprotease (MMP) enzymes involved in cellular remodeling and inflammation are also part of the pain process (Nat. Med., DOI: 10.1038/nm1723). Tests in rats and mice showed that nerve damage transiently increases production of MMP-9 in neurons and subsequently increases production of MMP-2. The team also found the MMPs wreak havoc by cleaving interleukin-1β and activating microglia and astrocytes, which have all previously been implicated in the pain process. Inhibiting MMP-9 blocks an early phase of pain associated with nerve injury, and blocking MMP-2 suppresses a late phase of pain. According to the researchers, the results suggest that inhibition of the MMP enzymes could "provide a novel therapeutic approach for the treatment of neuropathic pain."
This article has been sent to the following recipient: